15 minutes delayed
Comments
Loading...
Matinas BioPharma Hldgs (AMEX:MTNB) Stock, Earnings Estimates, EPS, And Revenue
Matinas BioPharma Hldgs reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 6
EPS Estimate
$-1.000
Quarterly Revenue Estimate
–
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of Matinas BioPharma Hldgs using advanced sorting and filters.
Data brought to you by Benzinga APIs
Matinas BioPharma Hldgs (MTNB) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-14 | $-1.00 | $-1.00 | 0.00 % |
| Mar 2024 | 2024-05-09 | $-1.50 | $-1.50 | 0.00 % |
| Sep 2023 | 2023-11-08 | $-1.50 | $-1.50 | 0.00 % |
| Jun 2023 | 2023-08-09 | $-1.50 | $-1.50 | 0.00 % |
Matinas BioPharma Hldgs (MTNB) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2023 | 2023-05-10 | $1.10M | $300.00K | 265.3 % |
| Dec 2022 | 2023-03-15 | $1.06M | $1.10M | -3.36 % |
| Sep 2022 | 2022-11-02 | $0 | $830.00K | -100.0 % |
| Jun 2022 | 2022-08-11 | $1.06M | $100.00K | 963.0 % |
FAQ
When is Matinas BioPharma Hldgs (AMEX:MTNB) reporting earnings?
Matinas BioPharma Hldgs (MTNB) is scheduled to report earnings on November 6, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
What were the latest earnings per share (EPS) for Matinas BioPharma Hldgs (AMEX:MTNB)?
The Actual EPS was $-1.00, which hit the estimate of $-1.00.
What were Matinas BioPharma Hldgs’s (AMEX:MTNB) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.